Diality Raises $12.5M for its Portable Home HD System
Expected to be flexible, easy to use, and portable, the pipeline Diality machine has obtained development support in a Series B investment round. CEO Osman Khawar pointed to rising costs and poor outcomes for in-center HD the COVID-19 pandemic as factors driving a push for home treatments.
Read the full article » | Posted 11-12-2020
Related Articles
- Proof of Concept for Silicon Nanopore Membrane Implantable HD Posted 10-05-2026
- AWAK PD To Go Posted 10-05-2026
- The Lancet Digital Health published results of Humacyte’s Phase III clinical trial of its V007 acellular tissue engineered vessel (ATEV) HD access Posted 09-18-2026
- Humacyte, Inc. announced Robert J. Kossman, MD, FACP, FASN and Prabir Roy-Chaudhury, MD, PhD, FASN have joined the company as advisors. Posted 08-21-2026

